OX40L blockade and allergen-induced airway responses in subjects with mild asthma - Wikidata - awgldk - TriplyDB

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

http://www.wikidata.org/entity/Q34620982

about

Mepolizumab versus placebo for asthma Pathogenic CD4+ T cells in patients with asthma.Allergen-induced asthma Bronchial asthma: is personalized therapy on the horizon?The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses OX40L blockade protects against inflammation-driven fibrosis.IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.Thymic stromal lymphopoietin: a central regulator of allergic asthma.Emerging biologics for the treatment of chronic rhinosinusitis.The importance of co-stimulation in the orchestration of T helper cell differentiation.EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.OX40, OX40L and Autoimmunity: a Comprehensive Review.Novel monoclonal treatments in severe asthma.Bifunctional Drugs for the Treatment of Respiratory Diseases.Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen.Treatment with anti-OX40L or anti-TSLP does not alter the frequency of T regulatory cells in allergic asthmatics.Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.Adjustment of sensitisation and challenge protocols restores functional and inflammatory responses to ovalbumin in guinea-pigs.As strong as an OX or as weak as a kitten?Developments in the field of allergy in 2016 through the eyes of Clinical and Experimental Allergy.New blood: Creative funding of disease-specific research.Anti-IL5 therapies for asthma.Role of the TSLP/DC/OX40L pathway in asthma pathogenesis and airway inflammation in mice.Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients.Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

P2860

Q24186306-D1CDE882-0DC1-4685-9F3C-FDDE114C7835 Q30252507-CD29233F-117F-4471-916E-5447F1D6CB5A Q34344131-FADB7B05-1A86-4621-9F70-5A959CB0864D Q35777120-A4A4B9C9-F8E0-4130-8852-12113372A671 Q36940326-B3ECA879-EDD4-4BCD-AF4C-F9326A1B6B65 Q37086713-1E63DE06-113C-4E1D-8A32-29AFEFA4297A Q37106475-BF7ED3CF-431E-46CC-8F30-DDDB6576D003 Q37625474-635A3D11-9705-4CF1-9907-A321A3D9CC4C Q38220362-09D77D26-365D-4827-B8F1-2890FA591A5D Q38344266-F2EC7331-5853-4E49-B5A2-F7D78AD1A277 Q38388255-DB5DDD22-1109-4DA5-A2C4-BAD17C2FA6B6 Q38394577-805FCCF2-B86E-4E93-B2EF-6917443BE1FD Q38555213-064BFC8E-141A-4E50-9F0D-FC47261FF15E Q38911706-FF52A9CA-F559-4525-A4B2-AEF0114D2B88 Q38992596-D64B848E-1AB6-48F9-9000-CF761A6E7D4C Q40435122-5A38F4C6-C035-4B5C-B943-C352F872C31E Q40692903-53F9D788-2C8B-4887-9D72-1125FDFA7698 Q40940984-C8FA46FB-5B3F-4167-B209-8F09204F0E5B Q41101471-1C969836-E23F-410E-B4A8-3D1FA154DFF8 Q41643876-EC566B4A-D57D-42FA-A0A0-69534E403481 Q43198422-73A6803D-A123-40E5-9DED-5C21F96F44CA Q43453858-1FA78FC8-CE79-4130-8EC6-9A55B6DB5099 Q45070970-F281BABB-A5F7-40FC-B40E-1106C9E43F5C Q45954284-62D0C0A6-4906-4EF7-9753-E15DC6B9D9D4 Q47551081-95F8576E-022A-425F-8BB1-20A0FA124187 Q50099445-6D8998CA-92CC-4DA1-AE35-3D9949FFC718 Q53146228-3ECAF4E4-F307-44E9-9C9D-2CC29795F49C Q55284399-29C55F68-2337-4053-B13A-04F990075A0E Q57401735-C0577396-E481-4A39-B1AB-0E2B7B99367D

P2860

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

http://www.wikidata.org/entity/Q34620982

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@ast

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@en

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@nl

type

label

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@ast

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@en

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@nl

prefLabel

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@ast

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@en

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@nl

P1433

Q34620982-95FC154F-8168-4D71-96B0-3CE392091740

P1476

Q34620982-7334BD03-D0D8-4C7A-A738-439E5C935C9E

P2093

Q34620982-0E6F9A12-F47E-4391-940E-0A3CC1C48EC9

Q34620982-23B835D2-C6DA-461F-AC2D-2190B95927D5

Q34620982-333A3F96-F1DD-4F01-BC20-56A9106C4E20

Q34620982-353223A4-7D42-4D40-8C53-8539B48F3F46

Q34620982-428C3DA1-E41A-46F8-9212-2F0A4C956516

Q34620982-4CDFEF1D-508D-4FB0-8364-6DF964780AE4

Q34620982-5EDE3019-8B6F-4536-B3E9-0334B2F8097A

Q34620982-86D60A1C-13A7-4B34-BDE1-BDA0E0870821

Q34620982-B299468D-A039-45F8-8AFD-45F422513A4D

Q34620982-BF3BB8B9-AD70-43A1-8B08-3E083FB92CC6

P2860

Q34620982-3202A68A-B148-4442-9CEC-367329398440

Q34620982-3D5EBD77-E112-4E8C-BC24-91E9159C6885

Q34620982-48EAED90-72F7-4035-A400-62250EF95BB4

Q34620982-4E837A2C-F5C5-47BA-859C-AE8D1B66D3AF

Q34620982-52BF2CC3-99C2-4FFB-BBFD-7FBE94D38482

Q34620982-52DB925C-D36D-4605-B07A-2E1F3B70D0AC

Q34620982-68BF12F0-CBCE-4B7D-AB45-5804294D7A1A

Q34620982-7C1A15C1-6627-47C2-90B9-8A2B675D8CAA

Q34620982-8345ACB6-AFD9-46E7-83F1-47DF30B31575

Q34620982-9CE87E29-6D04-4F7B-BD69-08B8388A9C01

P304

Q34620982-8DFF97F7-C4FE-435F-B796-C7AEE230BF72

P31

Q34620982-26D63658-0A2A-4A54-BDCB-1871F8B35392

P356

Q34620982-ADACB976-B758-456F-AE4E-C8FE307E564E

P433

Q34620982-B4D10C22-E146-4A08-912A-E522D84B534C

P478

Q34620982-82D2B145-2A94-4543-98B7-509C17D1E19B

P50

Q34620982-68351EF1-B23E-40CF-ADEB-E1EDA19B58F2

P577

Q34620982-D7EF4B30-9D4B-4271-AE04-98D524ECDC09

P5875

Q34620982-791F0F2C-1AAA-4F7F-9A0B-E9FC74DE7323

P698

Q34620982-CE1B5FD2-1ED0-427F-B1B4-F8B856BE503A

P921

Q34620982-EACC6F2B-AC82-4A20-AB05-B3365412500E

P932

Q34620982-985E40CE-BA7A-4987-B59B-E2CF89CB6C9C

P356

P1433

Clinical & Experimental Allergy

P1476

OX40L blockade and allergen-induced airway responses in subjects with mild asthma

@en

P2093

B Dua

http://www.w3.org/2001/XMLSchema#string

B E Davis

http://www.w3.org/2001/XMLSchema#string

C Carlsten

http://www.w3.org/2001/XMLSchema#string

C Kipling

http://www.w3.org/2001/XMLSchema#string

D McClintock

http://www.w3.org/2001/XMLSchema#string

D W Cockcroft

http://www.w3.org/2001/XMLSchema#string

G M Gauvreau

http://www.w3.org/2001/XMLSchema#string

H Scheerens

http://www.w3.org/2001/XMLSchema#string

I Mayers

http://www.w3.org/2001/XMLSchema#string

J G Matthews

http://www.w3.org/2001/XMLSchema#string

P2860

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation

A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation.

Airway wall expression of OX40/OX40L and interleukin-4 in asthma

Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma.

IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.

OX40/OX40 ligand interactions in T-cell regulation and asthma

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation

OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation.

P304

29-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEA.12235

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258512019

http://www.w3.org/2001/XMLSchema#string

P698

24224471

http://www.w3.org/2001/XMLSchema#string

P921

P932

4253735

http://www.w3.org/2001/XMLSchema#string